, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

down 80.20 %

Amarin Corporation Plc (AMRN) downgraded to Hold by Aegis Capital

Posted on: Thursday,  Oct 17, 2013  8:25 AM ET by Aegis Capital

Aegis Capital rated Hold Amarin Corporation Plc (NASDAQ: AMRN) on 10/17/2013. Previously Aegis Capital rated Buy Amarin Corporation Plc (NASDAQ: AMRN) on
12/10/2012., when the stock price was $9.85. Since then, Amarin Corporation Plc has lost 80.20% as of 10/17/2013's recent price of $1.95.
If you would have followed the previous Aegis Capital's recommendation on AMRN, you would have lost 80.2% of your investment in 311 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/17/2013 8:25 AM Hold
as of 12/13/2013
1 Week   
1 Month   
3 Months down  -70.45 %
1 YTD down  -75.89 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2012 8:25 AM Buy
9.85 35.00
12/7/2012 4:25 PM Buy
9.96 35.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy